Key points
- After hydrolyzed collagen is ingested, dipeptides such as Pro-Hyp (peaking at 1 to 2 hours) and Hyp-Gly appear in blood [5][6].
- A meta-analysis of 26 RCTs and 1721 participants associated oral collagen with better skin hydration and elasticity [2].
- In 2025, when split by funding, RCTs without industry funding showed no effect on hydration, elasticity or wrinkles [3].
- In osteoarthritis, collagen was associated with a 16.57-point reduction in VAS pain. The overall quality of evidence for osteoarthritis supplements is very low [8][9].
- With exercise, 15 g of vitamin C-enriched gelatin doubled a collagen synthesis marker in 8 volunteers [11].
US status (October 2026): See the peptide status tracker.
Oral collagen is safe, its peptides reach the blood, and its skin benefit disappears in independent, high-quality trials. The joint signal is short term and low quality. The most convincing physiology is in tendon, and only alongside exercise. That is the answer for the patient who asks.
Your patients already take this peptide
Long before BPC-157 or GHK-Cu reached social media, hydrolyzed collagen was already in millions of kitchens: powders, gummies and drinks taken for skin, hair or knees. It is a food product. It is also the peptide question you will hear most in clinic. A precise answer is worth having, because the literature is abundant: several meta-analyses of randomized trials in skin and joints [1][2][3][8]. Our post on peptides vs. supplements covers where the regulatory line falls.
Collagen peptides reach the blood intact
The classic objection is that collagen is digested to amino acids and never reaches any tissue intact. Pharmacokinetic data show something in between. In healthy volunteers who ingested 9.4 to 23 g of gelatin hydrolysates, peptide-form hydroxyproline rose from negligible amounts to a maximum of 20 to 60 nmol/mL of plasma at 1 to 2 hours, falling to half by 4 hours. The main component was the dipeptide Pro-Hyp [5].
A second dipeptide, Hyp-Gly, was detected in the blood of 4 of 5 participants, was more resistant to serum peptidases than Pro-Hyp, and stimulated mouse fibroblast growth in culture more strongly [6]. Pro-Hyp was also associated, dose-dependently, with greater growth of mouse skin fibroblasts on collagen gel [7]. It is a plausible mechanism. It is also in vitro and animal evidence: it shows the peptides reach the blood, and it does not show a clinical effect.
The skin benefit fades in independent trials
The two most cited meta-analyses are favorable. The 2021 one included 19 randomized, double-blind trials with 1125 participants aged 20 to 70 (95% women) and found improvements over placebo in hydration, elasticity and wrinkles [1]. The 2023 one pooled 26 RCTs with 1721 patients and confirmed better hydration and elasticity. The hydration effect varied with collagen source and duration, and the authors identified several biases in the included trials [2].
A typical trial in the field helps explain that literature: 69 women aged 35 to 55, 8 weeks, instrument-based outcomes. Elasticity improved significantly versus placebo. Hydration did not reach statistical significance [4]. These are small, short studies that measure the skin with instruments, which is different from outcomes patients notice.
In 2025, a meta-analysis in The American Journal of Medicine did what earlier ones had not: analyze by funding source and quality. With all 23 RCTs (1474 participants) pooled, collagen improved hydration, elasticity and wrinkles. Studies without company funding showed no effect on any of the three outcomes, while funded ones did. High-quality studies also showed no significant effect [3]. The authors concluded: “There is currently no clinical evidence to support the use of collagen supplements to prevent or treat skin aging” [3].
- 1721: participants in 26 RCTs in the favorable 2023 meta-analysis [2]
- 23: RCTs reanalyzed in 2025, with no effect in those without industry funding [3]
- 16.57: points of VAS pain reduction in osteoarthritis vs placebo [8]
Joints show a short-term signal in osteoarthritis only
A meta-analysis of placebo-controlled RCTs in osteoarthritis found a reduction in total WOMAC (weighted mean difference -8.00) and in VAS pain (-16.57). The WOMAC pain and function subscales were not significant. Only stiffness was [8]. A broader review of osteoarthritis supplements placed collagen hydrolysate among seven with a large short-term effect on pain, and undenatured type II collagen among two with a clinically important medium-term effect. No supplement showed a clinically important long-term effect, and overall quality of evidence was very low [9].
Outside diagnosed osteoarthritis, the result was negative. In 167 active people with self-reported knee pain, 12 weeks of collagen peptides reduced VAS pain no more than placebo (-1.6 vs -1.9, p = 0.42), with no change in inflammatory, cartilage or bone markers [10].
Tendon data are small and always paired with exercise
The most interesting area physiologically is connective tissue under load. In a crossover study of 8 healthy men, taking 15 g of vitamin C-enriched gelatin one hour before 6 minutes of rope-skipping doubled blood amino-terminal propeptide of collagen I (PINP). Serum drawn after gelatin also increased the collagen content of tissue-engineered ligaments [11].
Clinically, a pilot study of 20 patients with chronic Achilles tendinopathy combined collagen peptides with a calf-strengthening program for 6 months. At 3 months, the VISA-A score rose 12.6 points with collagen versus 5.3 with placebo, with no adverse events [12]. The signal is consistent with the mechanistic study. It comes from very small samples and always alongside exercise [11][12].
The limits, plainly
- Funding bias. The skin effect appears in industry-funded trials and disappears in independent ones [3].
- Heterogeneity. Different collagen sources, durations and measurement methods, with biases flagged by the meta-analysts themselves [2].
- Size and duration. Trials of dozens of participants and weeks of follow-up [4][11][12].
- Safety. The most reassuring point. In osteoarthritis there were no differences from placebo in safety outcomes, and the skin and tendon trials reported no adverse effects [4][9][12].
What to tell the patient
An honest answer fits in a few sentences. Oral collagen is a safe food whose peptides do reach the blood [5][6][9]. For skin, the body of trials is favorable, and the benefit is not confirmed in independent, higher-quality studies [1][2][3]. In osteoarthritis there is a short-term signal, with very low-quality evidence [8][9]. In undiagnosed knee pain, it did not beat placebo [10]. The physiology is most convincing in tendon, always combined with exercise [11][12].
The patient already taking collagen does not need a scolding. They need realistic expectations. Frame it as a low-risk complement that does not replace indicated treatment, and explain what the independent evidence says. A common question becomes a chance for you to be the reference [3][9]. If you run a peptide program, use the same funding-and-quality test on every product you are pitched.
References
- de Miranda RB, Weimer P, Rossi RC. Effects of hydrolyzed collagen supplementation on skin aging: a systematic review and meta-analysis. Int J Dermatol. 2021;60(12):1449-1461. PMID 33742704. Link
- Pu SY, et al. Effects of Oral Collagen for Skin Anti-Aging: A Systematic Review and Meta-Analysis. Nutrients. 2023;15(9):2080. PMID 37432180. Link
- Myung SK, Park Y. Effects of Collagen Supplements on Skin Aging: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Am J Med. 2025;138(9):1264-1277. PMID 40324552. Link
- Proksch E, et al. Oral supplementation of specific collagen peptides has beneficial effects on human skin physiology: a double-blind, placebo-controlled study. Skin Pharmacol Physiol. 2014;27(1):47-55. PMID 23949208. Link
- Iwai K, et al. Identification of food-derived collagen peptides in human blood after oral ingestion of gelatin hydrolysates. J Agric Food Chem. 2005;53(16):6531-6. PMID 16076145. Link
- Shigemura Y, et al. Identification of a novel food-derived collagen peptide, hydroxyprolyl-glycine, in human peripheral blood by pre-column derivatisation with phenyl isothiocyanate. Food Chem. 2011;129(3):1019-24. PMID 25212331. Link
- Shigemura Y, et al. Effect of Prolyl-hydroxyproline (Pro-Hyp), a food-derived collagen peptide in human blood, on growth of fibroblasts from mouse skin. J Agric Food Chem. 2009;57(2):444-9. PMID 19128041. Link
- García-Coronado JM, et al. Effect of collagen supplementation on osteoarthritis symptoms: a meta-analysis of randomized placebo-controlled trials. Int Orthop. 2019;43(3):531-538. PMID 30368550. Link
- Liu X, et al. Dietary supplements for treating osteoarthritis: a systematic review and meta-analysis. Br J Sports Med. 2018;52(3):167-175. PMID 29018060. Link
- Bongers CCWG, et al. Effectiveness of collagen supplementation on pain scores in healthy individuals with self-reported knee pain: a randomized controlled trial. Appl Physiol Nutr Metab. 2020;45(7):793-800. PMID 31990581. Link
- Shaw G, et al. Vitamin C-enriched gelatin supplementation before intermittent activity augments collagen synthesis. Am J Clin Nutr. 2017;105(1):136-143. PMID 27852613. Link
- Praet SFE, et al. Oral Supplementation of Specific Collagen Peptides Combined with Calf-Strengthening Exercises Enhances Function and Reduces Pain in Achilles Tendinopathy Patients. Nutrients. 2019;11(1):76. PMID 30609761. Link
This is general information, not medical or legal advice. Rules vary by state and change. Confirm your own facts with counsel.